| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/24/1999 | WO1999031085A1 3-piperidyl-4-oxoquinazoline derivatives and medicincal compositions containing the same |
| 06/24/1999 | WO1999031077A1 Arylpiperazines having activity at the serotonin 1a receptor |
| 06/24/1999 | WO1999031074A2 ((cyclo)alkyl substituted)-.gamma.-aminobutyric acid derivatives (=gaba analogues), their preparation and their use in the treatment of neurological disorders |
| 06/24/1999 | WO1999031066A1 Pyridones as src family sh2 domain inhibitors |
| 06/24/1999 | WO1999031063A1 New piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides |
| 06/24/1999 | WO1999031061A1 Integrin receptor antagonists |
| 06/24/1999 | WO1999031057A1 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 06/24/1999 | WO1999031051A1 1-(adamantyl)amidines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission |
| 06/24/1999 | WO1999031049A1 Neuroprotective agents |
| 06/24/1999 | WO1999031047A1 Cyclohexene carboxylates as neuraminidase inhibitors |
| 06/24/1999 | WO1999030738A2 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products |
| 06/24/1999 | WO1999030733A1 Method to enhance an immune response of nucleic acid vaccination |
| 06/24/1999 | WO1999030732A1 Gamma-conopeptides |
| 06/24/1999 | WO1999030729A1 Compositions and methods for regulating phagocytosis and icam-1 expression |
| 06/24/1999 | WO1999030727A1 Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
| 06/24/1999 | WO1999030725A1 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators |
| 06/24/1999 | WO1999030720A1 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha |
| 06/24/1999 | WO1999030713A1 Integrin receptor antagonists |
| 06/24/1999 | WO1999030712A1 Agents |
| 06/24/1999 | WO1999030710A1 USE OF PYRAZOLO [3,4-b] PYRIDINE AS CYCLIN DEPENDENT KINASE INHIBITORS |
| 06/24/1999 | WO1999030709A1 Integrin receptor antagonists |
| 06/24/1999 | WO1999030707A1 Multicatalytic protease inhibitors for use as anti-tumor agents |
| 06/24/1999 | WO1999030706A1 ANTIHYPERLIPIDEMIC STATIN-LP(a) INHIBITOR COMBINATIONS |
| 06/24/1999 | WO1999030704A1 Statin-carboxyalkylether combinations |
| 06/24/1999 | WO1999030700A1 Immunoglobulin-rich milk, production and use thereof |
| 06/24/1999 | WO1999030699A1 Modulators of cysteine protease |
| 06/24/1999 | WO1999030697A2 Combination effective for the treatment of impotence |
| 06/24/1999 | WO1999030696A1 A method for the prevention and treatment of stunned myocardium |
| 06/24/1999 | WO1999030692A1 IMPROVED HMG CoA REDUCTASE INHIBITOR EXTENDED RELEASE FORMULATION |
| 06/24/1999 | WO1999030670A2 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof |
| 06/24/1999 | WO1999030562A1 Method for treating fibroproliferative disorders by inhibitors of protein hydroxylation |
| 06/24/1999 | WO1999019480A3 Human receptor proteins; related reagents and methods |
| 06/24/1999 | WO1999016888A3 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 06/24/1999 | DE19756388A1 New 2-aryl-4-amino-6,7-di:methoxy-quinazoline derivatives useful as guanylate cyclase activators for treating cardiovascular diseases, etc. |
| 06/24/1999 | DE19756036A1 New indole amide derivatives |
| 06/24/1999 | CA2730373A1 Treatment of cancer having overexpression of erbb2 with anti-erbb2 antibodies and a hormonal chemotherapeutic agent |
| 06/24/1999 | CA2506802A1 Arylpiperazines having activity at the serotonin 1a receptor |
| 06/24/1999 | CA2348660A1 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products |
| 06/24/1999 | CA2325368A1 Proteins for cancer cell specific induction of apoptosis and method for isolation thereof |
| 06/24/1999 | CA2315540A1 Agonists of metabotropic glutamate receptors and uses thereof |
| 06/24/1999 | CA2315370A1 Integrin receptor antagonists |
| 06/24/1999 | CA2315232A1 Integrin receptor antagonists |
| 06/24/1999 | CA2314993A1 Combination effective for the treatment of impotence |
| 06/24/1999 | CA2314899A1 Compositions and methods for regulating phagocytosis and icam-1 expression |
| 06/24/1999 | CA2314885A1 Pharmaceutical compositions for mucolysis and treatment of inflammation |
| 06/24/1999 | CA2314884A1 Human tumor necrosis factor-r2-like proteins |
| 06/24/1999 | CA2314821A1 Methods for maintaining or restoring tissue-appropriate phenotype of soft tissue cells |
| 06/24/1999 | CA2314686A1 Gamma-conopeptides |
| 06/24/1999 | CA2314407A1 Immunoglobulin-rich milk, production and use thereof |
| 06/24/1999 | CA2314355A1 Use of pyrazolo ¢3,4-b! pyridine as cyclin dependent kinase inhibitors |
| 06/24/1999 | CA2314335A1 Purine derivatives having phosphodiesterase iv inhibition activity |
| 06/24/1999 | CA2314259A1 Multicatalytic protease inhibitors for use as anti-tumor agents |
| 06/24/1999 | CA2314141A1 Glucose regulated gene |
| 06/24/1999 | CA2313776A1 Triazine angiogenesis inhibitors |
| 06/24/1999 | CA2313651A1 Benzamine derivatives |
| 06/24/1999 | CA2313212A1 Modulators of cysteine protease |
| 06/24/1999 | CA2313125A1 Quinolinepiperazine and quinolinepiperidine derivatives, their preparation and their use as combined 5-ht1a, 5-ht1b and 5-ht1d receptor antagonists |
| 06/24/1999 | CA2313005A1 Method to enhance an immune response of nucleic acid vaccination |
| 06/24/1999 | CA2313004A1 3-substituted adenines via2-thioxanthines |
| 06/24/1999 | CA2311932A1 A method for the prevention and treatment of stunned myocardium |
| 06/24/1999 | CA2304612A1 Statin-carboxyalkylether combinations |
| 06/24/1999 | CA2299397A1 Antihyperlipidemic statin-lp(a) inhibitor combinations |
| 06/24/1999 | CA2280705A1 3-piperidyl-4-oxoquinazoline derivatives and pharmaceutical compositionscomprising the same |
| 06/23/1999 | EP0924205A1 Arylpiperazines having activity at the serotonin 1a receptor |
| 06/23/1999 | EP0923941A2 Remedies for myeloma to be used together with nitrogen mustard antitumor agents |
| 06/23/1999 | EP0923939A1 Methods and compositions for the treatment of infection and control of flora |
| 06/23/1999 | EP0923936A2 Flavor-improved extract from Cassia mimosoides L. var. nomame Makino and method of preparing the same |
| 06/23/1999 | EP0923585A1 Phosphinate based inhibitors of matrix metalloproteases |
| 06/23/1999 | EP0923582A1 Substituted 6,5-hetero-bicyclic derivatives |
| 06/23/1999 | EP0923573A1 Preparation of aminomethyl-phenylimidazoles |
| 06/23/1999 | EP0923569A1 Butyric acid matrix metalloproteinase inhibitors |
| 06/23/1999 | EP0923568A1 Novel benzofuran-4-carboxamides |
| 06/23/1999 | EP0923566A1 High molecular weight polymer-based prodrugs |
| 06/23/1999 | EP0923563A1 1,4-heterocyclic metallprotease inhibitors |
| 06/23/1999 | EP0923561A1 Heterocyclic metalloprotease inhibitors |
| 06/23/1999 | EP0923557A1 Stereoselective deoxygenation reaction |
| 06/23/1999 | EP0923551A1 4-aminoethoxy indolone derivatives |
| 06/23/1999 | EP0923550A1 Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists |
| 06/23/1999 | EP0923549A1 Methanesulphonate salt of an arylpiperazine derived from tryptamine and its solvates for pharmaceutical use |
| 06/23/1999 | EP0923548A1 4-aminoethoxy indoles as dopamin d2 agonists and as 5ht 1a? ligands |
| 06/23/1999 | EP0923547A1 Bidentate metalloprotease inhibitors |
| 06/23/1999 | EP0923546A1 Acylpyrroldicarboxylic acids and acylindoldicarboxylic acids and their derivatives and inhibitors of the cytosolic phospholipase a2 |
| 06/23/1999 | EP0923545A1 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors |
| 06/23/1999 | EP0923543A1 Potassium channel inhibitors |
| 06/23/1999 | EP0923530A1 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids |
| 06/23/1999 | EP0923529A1 Subsitute 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors |
| 06/23/1999 | EP0923379A1 Intravenous magnesium gluconate for treatment of conditions caused by excessive oxidative stress due to free radical distribution |
| 06/23/1999 | EP0923377A1 Therapeutic uses for an aminosterol compound |
| 06/23/1999 | EP0923373A1 Il-8 receptor antagonists |
| 06/23/1999 | EP0923287A1 Nonclassical pyrrolo 2,3-d]pyrimidine antifolates |
| 06/23/1999 | EP0502117B1 Pharmaceutical compositions comprising polymers with alkyl- or heteroalkyl-aryl backbone |
| 06/23/1999 | CN1220699A Antibodies against interferon alpha/beta receptor |
| 06/23/1999 | CN1220670A Inhibitor and stimulator of stem cell proliferationa and use thereof |
| 06/23/1999 | CN1220660A Alkyloxyamino substituted fluorenones and their use as protein kinase cinhibitors |
| 06/23/1999 | CN1220658A Galcium receptor-active compound |
| 06/23/1999 | CN1220656A Novel trienoic retinoid compounds and method |
| 06/23/1999 | CN1220608A Mammalian tolloid-like gene and protein |
| 06/23/1999 | CN1220270A Improved process for stabilizing proteins |
| 06/23/1999 | CN1220266A Intermediates of protein kinase C inhibitors and preparation process thereof |
| 06/23/1999 | CN1220262A 7-phenyl-1,4-stable derivative, its preparing method and medicine containing said compound |